Seres Therapeutics
MCRB
MCRB
78 hedge funds and large institutions have $274M invested in Seres Therapeutics in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.07% less ownership
Funds ownership: 3.98% → 3.91% (-0.07%)
3% less funds holding
Funds holding: 80 → 78 (-2)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
Holders
78
Holding in Top 10
1
Calls
$408K
Puts
$144K
Top Buyers
| 1 | +$7.39M | |
| 2 | +$3.6M | |
| 3 | +$743K | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$637K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$437K |
Top Sellers
| 1 | -$6.08M | |
| 2 | -$2.58M | |
| 3 | -$1.54M | |
| 4 |
Renaissance Technologies
New York
|
-$1.25M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.07M |